Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00008086 · ClinicalTrials.gov registry record · Phase 1
Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors
A Phase 1 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00008086: Completed Phase 1 study, sponsored by University of Pittsburgh.
NCT00008086 is a Phase 1 study that has completed, run by University of Pittsburgh. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00008086, a Phase 1 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Calcitriol may help solid tumor cells develop into normal cells. Combining calcitriol with chemotherapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of calcitriol combined with carboplatin in treating patients who have advanced solid tumors.
Interventions
- DRUG carboplatin
- DIETARY_SUPPLEMENT calcitriol
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-01 |
| Est. Completion | 2004-09 |
| Phase | Phase 1 |
What the finished NCT00008086 record still lists
NCT00008086 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which carboplatin is the first listed.
NCT00008086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00008086 about?
NCT00008086 is a clinical study titled "Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Calcitriol may help solid tumor cells develop into normal cells. Combining calcitriol with chemotherapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectivenes...
What is the current status of trial NCT00008086?
This trial is currently completed. It is a Phase 1 study. The study started on 1996-01. Estimated completion is 2004-09.
What interventions are being tested in trial NCT00008086?
The interventions under investigation include: carboplatin (DRUG), calcitriol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00008086?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia